BioCardia, Inc. (BCDA) Free cash flow 2017–2025
BioCardia, Inc. (BCDA) annual free cash flow history — operating cash flow minus capital expenditures, per SEC filings.
-$7.4MFY2025 · since FY2017: -$8.8M → -$7.4M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$7.4M | +5.7% |
| FY2024 | -$7.9M | +21.0% |
| FY2023 | -$10.0M | +6.1% |
| FY2022 | -$10.6M | -1.4% |
| FY2021 | -$10.5M | +15.4% |
| FY2020 | -$12.4M | -29.2% |
| FY2019 | -$9.6M | +13.9% |
| FY2018 | -$11.1M | -26.4% |
| FY2017 | -$8.8M | — |
Free cash flow = reported operating cash flow − reported capital expenditures for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice
More BCDA financial trends
BCDA RevenueBCDA Net incomeBCDA Net marginBCDA Gross profitBCDA Gross marginBCDA Operating incomeBCDA Operating marginBCDA Operating cash flowBCDA Capital expendituresBCDA Return on equityBCDA Stock buybacksBCDA Dividends paidBCDA Total assetsBCDA Total liabilitiesBCDA Shareholders’ equityBCDA overview →